e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Proteases and the matrix
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: Effect of COPD bronchial colonization in MMP-9:TIMP-1 molar ratio
L. Millares, A. Marín, J. García-Aymerich, J. Belda, J. Sauleda, S. Barea, M. García-Nuñez, M. Benet, J. M. Antó, E. Monsó (Badalona, Barcelona, Valencia, Palma de Mallorca, Spain)
Source:
Annual Congress 2010 - Proteases and the matrix
Session:
Proteases and the matrix
Session type:
Thematic Poster Session
Number:
4363
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Millares, A. Marín, J. García-Aymerich, J. Belda, J. Sauleda, S. Barea, M. García-Nuñez, M. Benet, J. M. Antó, E. Monsó (Badalona, Barcelona, Valencia, Palma de Mallorca, Spain). Late Breaking Abstract: Effect of COPD bronchial colonization in MMP-9:TIMP-1 molar ratio. Eur Respir J 2010; 36: Suppl. 54, 4363
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Late Breaking Abstract - EvA consortium: bronchial brush bacterial load is associated with airway remodelling in mild-to-moderate COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017
Late Breaking Abstract: Expression of S100A4 in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Late Breaking Abstract - Intra-alveolar neutrophil-derived microvesicles: a biomarker of COPD severity
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Late Breaking Abstract - Effects of a new Airway Clearance Technology versus manual physiotherapy in COPD
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018
Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021
Late Breaking Abstract - Benefits of a low-frequency airway clearance technology in non-CF patients with bronchiectasis
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018
Late Breaking Abstract: Persistent effect of bronchial thermoplasty (BT) in severe asthma at two years
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Late Breaking Abstract - Lung deflation with Indacaterol/Glycopyrronium improves cardiac function in COPD patients: The CLAIM Study
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Late Breaking Abstract - Association of lung clearance index with survival in patients with cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
Late Breaking Abstract: Detecting peripheral airway closure in airway disease by fluctuation analysis
Source: Annual Congress 2010 - Spotlight on lung function
Year: 2010
Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD
Source: International Congress 2017 – Late-breaking studies in asthma and COPD
Year: 2017
Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020
Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017
Late Breaking Abstract - Airway hyperresponsiveness in bronchiectasis
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019
Late Breaking Abstract - Association between blood eosinophils and exacerbation risk in COPD primary care
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept